Yang, HaiqiangCao, JessicaLin, XiaoyangYue, JingwenZieneldien, TarekKim, JaniceWang, LianchunFang, JianminHuang, Ruo-PanBai, YunSneed, KevinCao, Chuanhai2022-03-172022-03-172022Yang, Haiqiang, Cao, Jessica, Lin, Xiaoyang, et al.. "Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models." <i>Viruses,</i> 14, no. 3 (2022) MDPI: https://doi.org/10.3390/v14030449.https://hdl.handle.net/1911/112023Coronavirus disease 2019 (COVID-19) has caused massive health and economic disasters worldwide. Although several vaccines have effectively slowed the spread of the virus, their long-term protection and effectiveness against viral variants are still uncertain. To address these potential shortcomings, this study proposes a peptide-based vaccine to prevent COVID-19. A total of 15 B cell epitopes of the wild-type severe acute respiratory coronavirus 2 (SARS-CoV-2) spike (S) protein were selected, and their HLA affinities predicted in silico. Peptides were divided into two groups and tested in C57BL/6 mice with either QS21 or Al(OH)3 as the adjuvant. Our results demonstrated that the peptide-based vaccine stimulated high and durable antibody responses in mice, with the T and B cell responses differing based on the type of adjuvant employed. Using epitope mapping, we showed that our peptide-based vaccine produced antibody patterns similar to those in COVID-19 convalescent individuals. Moreover, plasma from vaccinated mice and recovered COVID-19 humans had the same neutralizing activity when tested with a pseudo particle assay. Our data indicate that this adjuvant peptide-based vaccine can generate sustainable and effective B and T cell responses. Thus, we believe that our peptide-based vaccine can be a safe and effective vaccine against COVID-19, particularly because of the flexibility of including new peptides to prevent emerging SARS-CoV-2 variants and avoiding unwanted autoimmune responses.This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citedDeveloping an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice ModelsJournal articlehttps://doi.org/10.3390/v14030449